
|Slideshows|May 23, 2018
Antibody Testing in Patients With Neurological and Psychiatric Symptoms
Author(s)Veronica Hackethal, MD
New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Secondary Analysis Finds Oveporexton Improves Cognitive Function in Adults With Narcolepsy Type 1
2
Key Neurology Trial Readouts to Watch in Early 2026
3
Neuroprotective Agent Privosegtor Gains FDA Breakthrough Designation for Optic Neuritis
4
sNDA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis
5



























